EXPERIMENTAL CONDITION - ANNOTATIONS
The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml ).
Term: cyclic hydrocarbon
Accession: XCO:0000277
browse the term
Definition: Any organic compound whose molecules are composed only of hydrogen, the element with atomic number 1, and carbon, the element with atomic number 12, and whose carbon atoms form a continuous or closed chain linked by bonds that may be represented graphically by one or more circular or triangular forms.
Q
Mamtr1
Mammary tumor resistance QTL 1
IDA
RGD
PMID:12844486
RGD:631852
NCBI chr 5:12,789,751...113,558,310
Q
Mamtr2
Mammary tumor resistance QTL 2
IDA
RGD
PMID:14522903
RGD:724790
NCBI chr 2:7,887,772...12,654,247
Q
Mamtr3
Mammary tumor resistance QTL 3
IDA
RGD
PMID:14522903
RGD:724790
NCBI chr 2:32,373,770...43,665,178
Q
Mamtr4
Mammary tumor resistance QTL 4
IDA
RGD
PMID:14522903
RGD:724790
NCBI chr 2:16,491,740...61,491,740
Q
Mamtr5
Mammary tumor resistance QTL 5
IDA
65mg/kg body mass
RGD
PMID:17230524
RGD:1599390
NCBI chr 5:18,873,947...63,873,947
Q
Mamtr6
Mammary tumor resistance QTL 6
IDA
65mg/kg body mass
RGD
PMID:17230524
RGD:1599390
NCBI chr18:19,278,901...83,218,561
Q
Mamtr7
Mammary tumor resistance QTL 7
IDA
65mg/kg body mass
RGD
PMID:19052818
RGD:2302423
NCBI chr10:9,658,275...104,670,812
Q
Mamtr8
Mammary tumor resistance QTL 8
IDA
65mg/ml body mass
RGD
PMID:19052818
RGD:2302423
NCBI chr18:31,359,408...83,218,561
Q
Mcs1
Mammary carcinoma susceptibility QTL 1
IDA
RGD
PMID:8168109
RGD:61080
NCBI chr 2:7,887,772...23,319,447
Q
Mcs12
Mammary carcinoma susceptibility QTL 12
IDA
RGD
PMID:16266982
RGD:1559294
NCBI chr 5:58,973,449...60,051,321
Q
Mcs13
Mammary carcinoma susceptibility QTL 13
IDA
RGD
PMID:16266982
RGD:1559294
NCBI chr 5:63,190,890...69,927,503
Q
Mcs14
Mammary carcinoma susceptibility QTL 14
IDA
RGD
PMID:16266982
RGD:1559294
NCBI chr 5:76,369,776...80,813,390
Q
Mcs15
Mammary carcinoma susceptibility QTL 15
IDA
RGD
PMID:16568087
RGD:1581951
NCBI chr10:85,565,469...103,884,409
Q
Mcs16
Mammary carcinoma susceptibility QTL 16
IDA
RGD
PMID:16596452
RGD:1599317
NCBI chr 1:2,244,390...43,433,040
Q
Mcs17
Mammary carcinoma susceptibility QTL 17
IDA
RGD
PMID:16596452
RGD:1599317
NCBI chr 1:197,670,404...242,670,404
Q
Mcs18
Mammary carcinoma susceptibility QTL 18
IDA
RGD
PMID:16596452
RGD:1599317
NCBI chr 2:7,887,772...42,804,738
Q
Mcs19
Mammary carcinoma susceptibility QTL 19
IDA
RGD
PMID:16596452
RGD:1599317
NCBI chr 5:99,485,997...103,690,167
Q
Mcs2
Mammary carcinoma susceptibility QTL 2
IDA
RGD
PMID:9584103
RGD:61081
NCBI chr 7:19,032,807...35,526,300
Q
Mcs20
Mammary carcinoma susceptibility QTL 20
IDA
RGD
PMID:16596452
RGD:1599317
NCBI chr 9:13,533,770...42,791,750
Q
Mcs21
Mammary carcinoma susceptibility QTL 21
IDA
RGD
PMID:16596452
RGD:1599317
NCBI chr10:28,875,650...52,200,160
Q
Mcs22
Mammary carcinoma susceptibility QTL 22
IDA
RGD
PMID:16596452
RGD:1599317
NCBI chr18:52,539,763...63,933,058
Q
Mcs23
Mammary carcinoma susceptibility QTL 23
IDA
RGD
PMID:17404222
RGD:1601189
Q
Mcs24
Mammary carcinoma susceptibility QTL 24
IDA
RGD
PMID:17404222
RGD:1601189
NCBI chr 5:64,719,390...109,719,390
Q
Mcs25
Mammary carcinoma susceptibility QTL 25
IDA
65mg/kg body weight
RGD
PMID:20737482
RGD:4143380
NCBI chr 6:10,894,415...110,548,006
Q
Mcs26
Mammary carcinoma susceptibility QTL 26
IDA
65mg/kg body weight
RGD
PMID:20737482
RGD:4143380
NCBI chr 6:106,752,656...132,339,866
Q
Mcs27
Mammary carcinoma susceptibility QTL 27
IDA
65mg/kg body weight
RGD
PMID:20737482
RGD:4143380
NCBI chr13:43,437,904...47,841,255
Q
Mcs28
Mammary carcinoma susceptibility QTL 28
IDA
RGD
PMID:21205740
RGD:5684388
NCBI chr 5:77,743,239...78,039,084
Q
Mcs29
Mammary carcinoma susceptibility QTL 29
IDA
RGD
PMID:21205740
RGD:5684388
NCBI chr 5:77,816,155...77,988,860
Q
Mcs3
Mammary carcinoma susceptibility QTL 3
IDA
65mg/kg body weight
RGD
PMID:9584103
RGD:61081
NCBI chr 1:102,268,556...147,268,556
Q
Mcs4
Mammary carcinoma susceptibility QTL 4
IDA
65mg/kg body weight
RGD
PMID:9584103
RGD:61081
NCBI chr 8:16,290,444...61,290,444
Q
Mcs5
Mammary carcinoma susceptibility QTL 5
IDA
RGD
PMID:11139513
RGD:62417
NCBI chr 5:55,805,606...132,207,589
Q
Mcs6
Mammary carcinoma susceptibility QTL 6
IDA
RGD
PMID:11139513
RGD:62417
NCBI chr 7:26,737,401...63,902,784
Q
Mcs7
Mammary carcinoma susceptibility QTL 7
IDA
RGD
PMID:11139513
RGD:62417
NCBI chr10:72,224,939...107,211,142
Q
Mcs8
Mammary carcinoma susceptibility QTL 8
IDA
RGD
PMID:11139513
RGD:62417
NCBI chr14:3,813,074...24,531,477
Q
Mcsm1
Mammary carcinoma susceptibility modifier QTL 1
IDA
RGD
PMID:11139513
RGD:62417
NCBI chr 6:58,632,962...103,632,962
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all